Understanding US Physician and Pharmacist Attitudes Toward Biosimilar Products: A Qualitative Study

ConclusionsEducating physicians and pharmacists about biosimilars —including how biosimilarity is defined and operationalized, the structure of the biosimilar approval process, and how analytical data can ensure biosimilar safety and efficacy—will be important for reducing healthcare providers’ concerns and increasing biosimilar adoption in the US.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research